CVE-2015-10022: A vulnerability was found in IISH nlgis2
CVE-2015-10022 is a medium-severity flaw (CVSS 5.5) affecting nlgis2. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A vulnerability was found in IISH nlgis2. It has been declared as critical. Affected by this vulnerability is an unknown functionality of the file scripts/etl/custom_import.pl. The manipulation leads to sql injection. The identifier of the patch is 8bdb6fcf7209584eaf1232437f0f53e735b2b34c. It is recommended to apply a patch to fix this issue. The identifier VDB-217609 was assigned to this vulnerability.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.5 (Medium) |
| Attack vector | Adjacent network |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.7% (top 47%) |
| CISA exploited list | No |
| Weakness | CWE-89 |
| Published | 2023-01-07 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2015-10022?
nlgis2: upgrade to 2015-01-14. Exact commands for each OS are on this page.
Is CVE-2015-10022 being exploited?
CVE-2015-10022 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2015-10022 affect?
CVE-2015-10022 affects nlgis2. Severity is medium (CVSS 5.5). A vulnerability was found in IISH nlgis2. It has been declared as critical. Affected by this vulnerability is an unknown functionality of the file scripts/etl/custom_import.pl. The manipulation leads to sql injection. The identifier of the
How urgent is CVE-2015-10022?
Priority 32/100. No elevated risk signals yet.